Pharmacological aspects of neonatal antidepressant withdrawal.

@article{Horst2008PharmacologicalAO,
  title={Pharmacological aspects of neonatal antidepressant withdrawal.},
  author={Peter J G Ter Horst and Frank G. A. Jansman and Richard A van Lingen and J Smit and Lolkje de Jong-van den Berg and Jacobus R. B. J. Brouwers},
  journal={Obstetrical & gynecological survey},
  year={2008},
  volume={63 4},
  pages={267-79}
}
UNLABELLED Depression is common in reproductive age women, and continued pharmacologic treatment of depression during pregnancy may be necessary to prevent relapse, which could be harmful for both the fetus and the mother. Although data on drug safety are imperfect and incomplete, the benefits of antidepressant therapy during pregnancy generally outweigh the risks. Neonates who are exposed to antidepressant medications during gestation are at increased risk to have neonatal withdrawal syndrome… CONTINUE READING
12 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…